Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Korean J Radiol. 2019 Apr;20(4):683-692. doi: 10.3348/kjr.2018.0391.
We aimed to evaluate correlations between computed tomography (CT) parameters and pulmonary function test (PFT) parameters according to disease severity in patients with chronic obstructive pulmonary disease (COPD), and to determine whether CT parameters can be used to predict PFT indices.
A total of 370 patients with COPD were grouped based on disease severity according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) I-IV criteria. Emphysema index (EI), air-trapping index, and airway parameters such as the square root of wall area of a hypothetical airway with an internal perimeter of 10 mm (Pi10) were measured using automatic segmentation software. Clinical characteristics including PFT results and quantitative CT parameters according to GOLD criteria were compared using ANOVA. The correlations between CT parameters and PFT indices, including the ratio of forced expiratory volume in one second to forced vital capacity (FEV₁/FVC) and FEV₁, were assessed. To evaluate whether CT parameters can be used to predict PFT indices, multiple linear regression analyses were performed for all patients, Group 1 (GOLD I and II), and Group 2 (GOLD III and IV).
Pulmonary function deteriorated with increase in disease severity according to the GOLD criteria ( < 0.001). Parenchymal attenuation parameters were significantly worse in patients with higher GOLD stages ( < 0.001), and Pi10 was highest for patients with GOLD III (4.41 ± 0.94 mm). Airway parameters were nonlinearly correlated with PFT results, and Pi10 demonstrated mild correlation with FEV₁/FVC in patients with GOLD II and III ( = 0.16, = 0.06 and = 0.21, = 0.04, respectively). Parenchymal attenuation parameters, airway parameters, EI, and Pi10 were identified as predictors of FEV₁/FVC for the entire study sample and for Group 1 (R² = 0.38 and 0.22, respectively; < 0.001). However, only parenchymal attenuation parameter, EI, was identified as a predictor of FEV₁/FVC for Group 2 (R² = 0.37, < 0.001). Similar results were obtained for FEV₁.
Airway and parenchymal attenuation parameters are independent predictors of pulmonary function in patients with mild COPD, whereas parenchymal attenuation parameters are dominant independent predictors of pulmonary function in patients with severe COPD.
我们旨在根据慢性阻塞性肺疾病(COPD)患者的疾病严重程度,评估计算机断层扫描(CT)参数与肺功能测试(PFT)参数之间的相关性,并确定 CT 参数是否可用于预测 PFT 指标。
根据全球慢性阻塞性肺疾病倡议(GOLD)I-IV 标准,将 370 例 COPD 患者分为不同疾病严重程度组。使用自动分割软件测量肺气肿指数(EI)、空气滞留指数和气道参数,如假想气道内部周长为 10mm(Pi10)的平方根。使用方差分析比较不同 GOLD 标准的临床特征,包括 PFT 结果和定量 CT 参数。评估 CT 参数与 PFT 指数(包括一秒用力呼气量与用力肺活量的比值(FEV₁/FVC)和 FEV₁)之间的相关性。为了评估 CT 参数是否可用于预测 PFT 指数,对所有患者、GOLD 组 1(GOLD I 和 II)和 GOLD 组 2(GOLD III 和 IV)进行了多元线性回归分析。
根据 GOLD 标准,肺功能随疾病严重程度的增加而恶化(<0.001)。肺实质衰减参数在 GOLD 分期较高的患者中明显较差(<0.001),GOLD III 患者的 Pi10 最高(4.41±0.94mm)。气道参数与 PFT 结果呈非线性相关,Pi10 在 GOLD II 和 III 患者中与 FEV₁/FVC 呈轻度相关(=0.16,=0.06 和=0.21,=0.04)。肺实质衰减参数、气道参数、EI 和 Pi10 被确定为整个研究样本和 GOLD 组 1(R²=0.38 和 0.22,分别;<0.001)中 FEV₁/FVC 的预测因子。然而,只有肺实质衰减参数和 EI 被确定为 GOLD 组 2(R²=0.37,<0.001)中 FEV₁/FVC 的预测因子。FEV₁ 也得到了类似的结果。
在轻度 COPD 患者中,气道和肺实质衰减参数是肺功能的独立预测因子,而在重度 COPD 患者中,肺实质衰减参数是肺功能的主要独立预测因子。